Table 2.
Visual acuity in patients with central serous chorioretinopathy before and after half-dose photodynamic therapy
Case | Pretreatment | After treatment | Period of stable fixation* | |||
---|---|---|---|---|---|---|
|
||||||
1 month | 3 months | 6 months | 12 months | |||
1 | 0.9 | 1.0 | 1.2 | 1.5 | 1.5 | Pre |
2 | 0.7 | 0.6 | 0.6 | 0.8 | 0.7 | Pre |
3 | 1.0 | 1.0 | 1.5 | 1.5 | 1.5 | Pre |
4 | 1.5 | 1.2 | 1.5 | 1.5 | 1.5 | Pre |
5 | 0.7 | 0.7 | 0.8 | 1.0 | 1.0 | Pre |
6 | 0.15 | 0.1 | 0.15 | 0.2 | 0.2 | 1 month |
7 | 0.7 | 1.0 | 1.0 | 1.5 | 1.5 | Pre |
8 | 1.2 | 1.2 | 1.5 | 1.5 | 1.5 | Pre |
9 | 0.5 | 0.7 | 0.8 | 0.9 | 0.9 | Pre |
10 | 0.2 | 0.3 | 0.4 | 0.4 | 0.7 | 1 month |
11 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | 12 months |
12 | 0.7 | 0.7 | 0.9 | 0.9 | 0.9 | Pre |
13 | 0.9 | 0.9 | 1.0 | 1.0 | 1.5 | Pre |
14 | 0.9 | 0.7 | 1.0 | 1.5 | 1.2 | Pre |
Geomean** | 0.649 | 0.657 | 0.785 | 0.917 | 0.942 |
Notes:
The point when stable fixation was observed. ‘pre’ means the stable fixation was first observed already at pre-PDT.
Abbreviations: geomean, geometric mean; PDT, photodynamic therapy.